These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34387242)

  • 1. Modulation of Xenogeneic T-cell Proliferation by B7 and mTOR Blockade of T Cells and Porcine Endothelial Cells.
    Li S; Xu H; Kirk AD
    Transplantation; 2022 May; 106(5):950-962. PubMed ID: 34387242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xenorecognition and costimulation of porcine endothelium-derived extracellular vesicles in initiating human porcine-specific T cell immune responses.
    Li S; Anwar IJ; Canning AJ; Vo-Dinh T; Kirk AD; Xu H
    Am J Transplant; 2023 Jul; 23(7):904-919. PubMed ID: 37054891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+ T-cell and monocyte interdependence during discordant xenoimmune responses.
    Fang Y; Liu Z; Zhu L; Wang P; Wang Y; Xu H
    Transplant Proc; 2008 Oct; 40(8):2764-8. PubMed ID: 18929856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interleukin-2 receptor α chain (CD25) plays an important role in regulating monocyte-derived CD40 expression during anti-porcine cellular responses.
    Sun ZG; Wang Z; Zhu LM; Fang YS; Yu LZ; Xu H
    Transplant Proc; 2012 May; 44(4):1139-42. PubMed ID: 22564647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mTOR Inhibitor Therapy Diminishes Circulating CD8+ CD28- Effector Memory T Cells and Improves Allograft Inflammation in Belatacept-refractory Renal Allograft Rejection.
    Castro-Rojas CM; Godarova A; Shi T; Hummel SA; Shields A; Tremblay S; Alloway RR; Jordan MB; Woodle ES; Hildeman DA
    Transplantation; 2020 May; 104(5):1058-1069. PubMed ID: 31415033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapamycin-treated human endothelial cells preferentially activate allogeneic regulatory T cells.
    Wang C; Yi T; Qin L; Maldonado RA; von Andrian UH; Kulkarni S; Tellides G; Pober JS
    J Clin Invest; 2013 Apr; 123(4):1677-93. PubMed ID: 23478407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapamycin has suppressive and stimulatory effects on human plasmacytoid dendritic cell functions.
    Boor PP; Metselaar HJ; Mancham S; van der Laan LJ; Kwekkeboom J
    Clin Exp Immunol; 2013 Dec; 174(3):389-401. PubMed ID: 23968562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Everolimus (RAD001) combined with programmed death-1 (PD-1) blockade enhances radiosensitivity of cervical cancer and programmed death-ligand 1 (PD-L1) expression by blocking the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR)/S6 kinase 1 (S6K1) pathway.
    Song L; Liu S; Zhao S
    Bioengineered; 2022 Apr; 13(4):11240-11257. PubMed ID: 35485300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postdepletion Lymphocyte Reconstitution During Belatacept and Rapamycin Treatment in Kidney Transplant Recipients.
    Xu H; Samy KP; Guasch A; Mead SI; Ghali A; Mehta A; Stempora L; Kirk AD
    Am J Transplant; 2016 Feb; 16(2):550-64. PubMed ID: 26436448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programmed death (PD)-1 molecule and its ligand PD-L1 distribution among memory CD4 and CD8 T cell subsets in human immunodeficiency virus-1-infected individuals.
    Rosignoli G; Lim CH; Bower M; Gotch F; Imami N
    Clin Exp Immunol; 2009 Jul; 157(1):90-7. PubMed ID: 19659774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8+CD122+PD-1+ Tregs Synergize With Costimulatory Blockade of CD40/CD154, but Not B7/CD28, to Prolong Murine Allograft Survival.
    Liu H; Qiu F; Wang Y; Zeng Q; Liu C; Chen Y; Liang CL; Zhang Q; Han L; Dai Z
    Front Immunol; 2019; 10():306. PubMed ID: 30863408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of CD28-B7, but not CD40-CD154, prevents costimulation of allogeneic porcine and xenogeneic human anti-porcine T cell responses.
    Lee RS; Yamada K; Womer KL; Pillsbury EP; Allison KS; Marolewski AE; Geng D; Thall AD; Arn JS; Sachs DH; Sayegh MH; Madsen JC
    J Immunol; 2000 Mar; 164(6):3434-44. PubMed ID: 10706740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programmed Death-1 Inhibition of Phosphatidylinositol 3-Kinase/AKT/Mechanistic Target of Rapamycin Signaling Impairs Sarcoidosis CD4
    Celada LJ; Rotsinger JE; Young A; Shaginurova G; Shelton D; Hawkins C; Drake WP
    Am J Respir Cell Mol Biol; 2017 Jan; 56(1):74-82. PubMed ID: 27564547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of granzyme B expression in T-cell receptor/CD28-stimulated human regulatory T cells is suppressed by inhibitors of the PI3K-mTOR pathway.
    Efimova OV; Kelley TW
    BMC Immunol; 2009 Nov; 10():59. PubMed ID: 19930596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rabbit anti-human leukocyte polyclonal antibody inhibits xenogeneic cell-mediated immune responses.
    Zhu L; Fang Y; Liu Z; Wang P; Wang Y; Xu H
    Transplant Proc; 2008 Oct; 40(8):2760-3. PubMed ID: 18929855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-inhibitory profile and cytotoxicity of CD57
    Kraaijeveld R; de Graav GN; Dieterich M; Litjens NHR; Hesselink DA; Baan CC
    Clin Exp Immunol; 2018 Mar; 191(3):363-372. PubMed ID: 29027667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Siplizumab combination therapy with belatacept or abatacept broadly inhibits human T cell alloreactivity in vitro.
    Cvetkovski F; Razavi R; Sellberg F; Berglund E; Berglund D
    Am J Transplant; 2023 Oct; 23(10):1603-1611. PubMed ID: 37270108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mTOR Promotes Antiviral Humoral Immunity by Differentially Regulating CD4 Helper T Cell and B Cell Responses.
    Ye L; Lee J; Xu L; Mohammed AU; Li W; Hale JS; Tan WG; Wu T; Davis CW; Ahmed R; Araki K
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27974559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
    J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer group 2D and CD28 receptors differentially activate mammalian/mechanistic target of rapamycin to alter murine effector CD8+ T-cell differentiation.
    McQueen B; Trace K; Whitman E; Bedsworth T; Barber A
    Immunology; 2016 Mar; 147(3):305-20. PubMed ID: 26661515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.